CURASEN THERAPEUTICS
CuraSen Therapeutics is a biopharmaceutical company that develops orphan drugs to treat neurodegenerative diseases, including Parkinson's disease and Alzheimer's disease.
CURASEN THERAPEUTICS
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2016-01-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.curasen.com
Total Employee:
11+
Status:
Active
Contact:
+1 650 475 2842
Email Addresses:
[email protected]
Total Funding:
72.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Google Google Cloud Google Cloud Iowa
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Libra Therapeutics
Libra Therapeutics is a biotechnology company.
MOMA Therapeutics
MOMA Therapeutics operates as a biotechnology company.
Primmune Therapeutics
Primmune Therapeutics is a Biotechnology company.
Terray Therapeutics
Terray Therapeutics is a biotechnology company that propels drug discovery into the information age.
Current Advisors List
Current Employees Featured
Founder
Investors List
Pappas Capital
Pappas Capital investment in Series A - CuraSen Therapeutics
Chiesi Ventures
Chiesi Ventures investment in Series A - CuraSen Therapeutics
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Series A - CuraSen Therapeutics
Tekla Capital Management
Tekla Capital Management investment in Series A - CuraSen Therapeutics
New Leaf Venture Partners
New Leaf Venture Partners investment in Series A - CuraSen Therapeutics
Longitude Capital
Longitude Capital investment in Series A - CuraSen Therapeutics
Alta Partners
Alta Partners investment in Series A - CuraSen Therapeutics
Official Site Inspections
http://www.curasen.com Semrush global rank: 8.64 M Semrush visits lastest month: 274
- Host name: 95.6.226.35.bc.googleusercontent.com
- IP address: 35.226.6.95
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "CuraSen Therapeutics"
Leadership - CuraSen
Prior to CuraSen, Dr. Ford co-founded Afferent Pharmaceuticals, and as chief scientific officer led the discovery and development of first-in-class P2X3 antagonists, including AF-219/MK-7264 …See details»
About - CuraSen
CuraSen Therapeutics, Inc. is a privately funded biopharmaceutical company pursuing development of novel treatments for psychiatric and neurodegenerative diseases, including depression, Parkinson’s disease and Alzheimer’s disease, …See details»
CuraSen Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View CuraSen Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
CuraSen Therapeutics - Crunchbase Company Profile
Organization. CuraSen Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
CuraSen | VentureRadar
CuraSen Therapeutics, Inc. is developing drugs targeting a novel mechanism in the brain to restore function, improve symptoms and modify disease in a range of neurodegenerative …See details»
CuraSen Company Profile 2024: Valuation, Funding
CuraSen General Information Description. Operator of a biopharmaceutical company intended for the development of novel treatments for neurodegenerative diseases. The company engages in developing small molecules that target …See details»
CuraSen Therapeutics, Inc. | LinkedIn
CuraSen Therapeutics, Inc. is a privately funded biopharmaceutical company pursuing development of novel treatments for neurodegenerative diseases, including Parkinson’s …See details»
Curasen Therapeutics Inc. | Alzheimer's Drug Discovery Foundation
Sep 1, 2023 CuraSen’s unique approach restores LC impact using specific agonists for two of nine adrenergic receptors (β 2-, & α 1A-AR) identified within CuraSen to mediate cognitive …See details»
CuraSen Therapeutics - Contacts, Employees, Board Members
CuraSen Therapeutics has 8 current employee profiles, including Senior Vice President, Operations Peter G. Butera. CuraSen Therapeutics has 4 board members and advisors, …See details»
Curasen Therapeutics | CipherBio
Explore Curasen Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Science - CuraSen
CuraSen’s approach is focused on restoring the lost adrenergic impact of adequate noradrenaline stimulus by directly activating specific targets, such as the β 2 and α 1A adrenoceptors, for …See details»
CuraSen Therapeutics - Craft
CuraSen Therapeutics has 5 employees at their 1 location and $54.5 m in total funding,. See insights on CuraSen Therapeutics including office locations, competitors, revenue, financials, …See details»
CuraSen Therapeutics - Funding, Financials, Valuation & Investors
CuraSen Therapeutics is funded by 9 investors. Alzheimer's Drug Discovery Foundation and The Silverstein Foundation are the most recent investors. CuraSen Therapeutics has a post-money …See details»
CuraSen Therapeutics - Pappas Capital
CuraSen Therapeutics ← Back to Ventures Portfolio The company is developing small molecule drugs targeting a novel mechanism in the brain to modify disease pathology, and alleviate …See details»
Contact - CuraSen
Office Address 733 Industrial RoadSan Carlos CA 94070 Phone 650-475-2842 Email [email protected]See details»
curasan – The pioneers in Biosurgery!
With curasan’s orthobiologic solutions, biomaterials are specifically designed to mimic human bone while providing full solutions for regenerating tissue in Orthopaedics, Spine and …See details»
Careers - CuraSen
As an equal opportunity employer, CuraSen is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on …See details»
CuraSen - VentureRadar
Similar Companies: Muna Therapeutics Denmark Privately Held Muna Therapeutics is a private biopharmaceutical company founded in 2020 and based in Copenhagen, Denmark and …See details»
News - CuraSen
CuraSen Therapeutics to Present Phase 2 Data Showing Rapid-Onset Cognition and Mood Benefit with CST-103/CST-107 (Clenbuterol/Nadolol) in Parkinson’s Disease at the …See details»